Barjesh Chander Sharma Selected Research

Hepatic Encephalopathy

1/2022	L-ornithine L-aspartate in acute treatment of severe hepatic encephalopathy: A double-blind randomized controlled trial.
1/2018	L-ornithine L-aspartate in bouts of overt hepatic encephalopathy.
6/2017	Randomized controlled trial comparing lactulose plus albumin versus lactulose alone for treatment of hepatic encephalopathy.
1/2017	Sleep disturbances in patients of liver cirrhosis with minimal hepatic encephalopathy before and after lactulose therapy.
12/2016	Probiotics in management of hepatic encephalopathy.
6/2016	Spectral electroencephalogram in liver cirrhosis with minimal hepatic encephalopathy before and after lactulose therapy.
3/2016	Efficacy of Nutritional Therapy for Patients With Cirrhosis and Minimal Hepatic Encephalopathy in a Randomized Trial.
9/2015	Bispectral index monitoring for diagnosis and assessment of severity of hepatic encephalopathy in cirrhotic patients.
8/2015	Randomised controlled trial of lactulose versus rifaximin for prophylaxis of hepatic encephalopathy in patients with acute variceal bleed.
6/2014	Probiotics prevent hepatic encephalopathy in patients with cirrhosis: a randomized controlled trial.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Barjesh Chander Sharma Research Topics

Disease

25	Hepatic Encephalopathy 01/2022 - 09/2009
20	Fibrosis (Cirrhosis) 01/2019 - 07/2007
6	Liver Diseases (Liver Disease) 08/2011 - 04/2005
5	Infections 11/2019 - 04/2005
5	Hemorrhage 02/2018 - 12/2008
5	Chronic Hepatitis B 01/2018 - 11/2005
5	End Stage Liver Disease 06/2017 - 05/2010
5	Ascites 02/2012 - 04/2005
4	Brain Diseases (Brain Disorder) 01/2022 - 02/2012
4	Portal Hypertension 12/2015 - 12/2008
3	Acute-On-Chronic Liver Failure 02/2018 - 03/2011
3	Varicose Veins (Varicose Vein) 03/2013 - 10/2010
2	Hepatocellular Carcinoma (Hepatoma) 11/2019 - 05/2010
2	Shock 07/2018 - 10/2017
2	Liver Cirrhosis (Hepatic Cirrhosis) 01/2017 - 06/2016
2	Sepsis (Septicemia) 12/2015 - 03/2012
2	Peritonitis 12/2015 - 05/2010
2	Hepatorenal Syndrome 03/2012 - 03/2011
2	Jaundice (Icterus) 02/2012 - 03/2006
2	Alcoholic Hepatitis 03/2011 - 03/2009
2	Hepatitis B 03/2011 - 03/2006
1	COVID-19 07/2021
1	Coinfection 11/2019
1	Chronic Hepatitis C 03/2019
1	Chronic Renal Insufficiency 03/2019
1	Cross Infection (Nosocomial Infection) 03/2019
1	Parkinsonian Disorders (Parkinsonism) 01/2019
1	Hypokinesia (Bradykinesia) 01/2019
1	Sleep Initiation and Maintenance Disorders (Insomnia) 01/2019
1	Tremor (Tremors) 01/2019
1	Cholangitis 07/2018
1	Neoplasm Metastasis (Metastasis) 07/2018
1	Liver Failure 02/2018
1	Systemic Inflammatory Response Syndrome (Sepsis Syndrome) 10/2017
1	Sleepiness 01/2017
1	Neoplasms (Cancer) 03/2016
1	Wounds and Injuries (Trauma) 12/2015
1	Necrosis 12/2012
1	Fistula 02/2012
1	Liver Abscess 02/2012
1	Biliary Fistula 02/2012
1	Esophageal and Gastric Varices (Esophageal Varices) 06/2011
1	Gastric Antral Vascular Ectasia (Watermelon Stomach) 04/2010
1	Hepatopulmonary Syndrome 09/2008

Drug/Important Bio-Agent (IBA)

15	Lactulose (Duphalac)FDA LinkGeneric 01/2022 - 09/2009
8	AmmoniaIBA 01/2019 - 12/2012
6	Cytidine Triphosphate (CTP)IBA 01/2019 - 03/2011
5	Rifaximin (L 105)FDA Link 01/2022 - 06/2010
5	DNA (Deoxyribonucleic Acid)IBA 11/2019 - 03/2006
4	Hepatitis B Surface Antigens (HBsAg)FDA Link 11/2019 - 03/2006
4	BilirubinIBA 10/2017 - 03/2006
3	ornithylaspartateIBA 01/2022 - 08/2011
3	Antiviral Agents (Antivirals)IBA 11/2019 - 04/2005
3	Hepatitis B e AntigensIBA 01/2018 - 11/2005
3	EndotoxinsIBA 12/2016 - 12/2012
3	Propranolol (Inderal)FDA LinkGeneric 03/2013 - 09/2009
2	Interleukin-18 (Interleukin 18)IBA 07/2013 - 12/2012
2	Interleukin-6 (Interleukin 6)IBA 07/2013 - 12/2012
2	Propofol (Diprivan)FDA LinkGeneric 11/2012 - 06/2011
2	SodiumIBA 02/2012 - 05/2010
2	CyanoacrylatesIBA 06/2011 - 04/2010
2	Pentoxifylline (Trental)FDA LinkGeneric 03/2011 - 09/2008
2	Serum AlbuminIBA 09/2009 - 03/2006
2	Lamivudine (Epivir)FDA Link 01/2006 - 11/2005
1	AntigensIBA 07/2021
1	Dopamine (Intropin)FDA LinkGeneric 01/2019
1	Bromocriptine (Parlodel)FDA LinkGeneric 01/2019
1	Zolpidem (Ambien)FDA LinkGeneric 01/2019
1	perfluoro- 2,2,2',2'- tetramethyl- 4,4'- bis(1,3- dioxolane)IBA 07/2018
1	PotassiumIBA 10/2017
1	CreatinineIBA 10/2017
1	Urea (Carbamide)FDA LinkGeneric 10/2017
1	AlbuminsIBA 06/2017
1	PrebioticsIBA 12/2016
1	Dietary Plant Proteins (Vegetable Protein)IBA 03/2016
1	Therapeutic UsesIBA 03/2016
1	Glutamine (L-Glutamine)FDA Link 07/2013
1	DisaccharidesIBA 06/2013
1	lactitolIBA 06/2013
1	Anti-Infective Agents (Microbicides)IBA 06/2013
1	Midazolam (Versed)FDA LinkGeneric 11/2012
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 03/2012
1	N 30IBA 06/2011
1	Tenofovir (Viread)FDA Link 03/2011
1	Adrenergic Receptors (Adrenergic Receptor)IBA 10/2010
1	Infliximab (Remicade)FDA Link 03/2009
1	Alanine Transaminase (SGPT)IBA 05/2008
1	AntibodiesIBA 07/2007
1	ORALIT (ORS)IBA 07/2007
1	RNA (Ribonucleic Acid)IBA 07/2007
1	Immunologic Factors (Immunomodulators)IBA 01/2007

Therapy/Procedure

17	Therapeutics 01/2019 - 04/2005
3	Stents 02/2018 - 10/2006
3	Ligation 10/2010 - 09/2009
2	Aftercare (After-Treatment) 09/2015 - 07/2013
1	Blood Transfusion (Blood Transfusions) 03/2019
1	Renal Dialysis (Hemodialysis) 03/2019
1	Anesthesia 07/2018
1	Cholecystectomy 12/2015
1	Sclerotherapy 04/2010